Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.
Bichoupan, K.; Schwartz, J. M.; Martel-Laferriere, V.; Giannattasio, E. R.; Marfo, K.; Odin, J. A.; Liu, L. U.; Schiano, T. D.; Perumalswami, P.; Bansal, M.; Gaglio, P. J.; Kalia, H.; Dieterich, D. T.; Branch, A. D.; Reinus, J. F.; Alimentary Pharmacology & Therapeutics, 2014, vol. 39, issue 2, p 209, ISSN 02692813. ISBN 02692813.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef